Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke
Completed
Conditions studied: Stroke, Acute
In brief
The purpose of the research is to use plasma free fatty acid profiling as a biomarker for ischemic stroke. The plasma free acid profile will be specifically and significantly changed in early stages upon stroke onset, and correlate with the stroke volume and progression determined by imaging techniques.
Key facts
- Study ID
- NCT03618290
- Run by
- Sanford Health
- People needed
- 102
- Starts
- 2018-09-19
- Expected to finish
- 2020-01-07
- Last updated by the study team
- 2020-01-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have onset of symptoms within 24-hours of presentation (AIS and Brain ?Trauma arms only).
- 18-years old and older.
- Able to offer informed consent after passing the MMSE with score ≥18 or able to obtain consent from legally authorized representative if MMSE score is ≤17.
- Participants must be admitted to the hospital and stay for at least 24 hours.
- Present with a traumatic or non AIS-related brain injury (non-AIS brain injury arm only).
- Diagnosed with non-neurological pathology (non-neurological pathology arm only).
You may not qualify if…
- Have onset of symptoms more than 24-hours before presentation (AIS and Brain Trauma arms).
- Less than 18-years old.
- Patients unwilling to provide consent with MMSE score of 18 or greater.
- Legally authorized representative unable or unwilling to provide consent for patients with an MMSE score of 17 or less.
- If they leave the hospital within 24 hours after being admitted.
- No longer meeting the eligibility criteria.
Where it is running
- Sanford Health — Fargo, North Dakota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.